Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 32, Issue 6, Pages 913-917
Publisher
Wiley
Online
2017-04-05
DOI
10.1002/mds.27006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin therapy prevents the onset of Parkinson disease in patients with diabetes
- (2016) Kun-Der Lin et al. ANNALS OF NEUROLOGY
- Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis
- (2016) Katsiaryna Bykov et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
- (2015) Xuemei Huang et al. MOVEMENT DISORDERS
- APOE and LRPAP1 gene polymorphism and risk of Parkinson’s disease
- (2014) Neeraj Kumar Singh et al. NEUROLOGICAL SCIENCES
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Holding on to statins in Parkinson disease
- (2013) E.-K. Tan et al. NEUROLOGY
- Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort
- (2013) B. Mollenhauer et al. NEUROLOGY
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms
- (2012) Anil Kumar et al. BRAIN RESEARCH
- Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies
- (2012) Krishna Undela et al. JOURNAL OF NEUROLOGY
- Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
- (2011) Junqiang Yan et al. PLoS One
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Statin use and Parkinson's disease in Denmark
- (2010) Beate Ritz et al. MOVEMENT DISORDERS
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
- (2009) Andrew O. Koob et al. EXPERIMENTAL NEUROLOGY
- Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
- (2009) A. Ghosh et al. JOURNAL OF NEUROSCIENCE
- Use of Statins and the Risk of Parkinson???s Disease
- (2008) Claudia Becker et al. DRUG SAFETY
- Statin use and the risk of Parkinson disease: a nested case control study
- (2008) Ali Samii et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease
- (2008) Pazit Bar-On et al. JOURNAL OF NEUROCHEMISTRY
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Total cholesterol and the risk of Parkinson disease
- (2008) G. Hu et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now